Joltoo
InvestorsInsights
DeepTech 2026 Playbook
Browse all
  1. Home
  2. /Investors
  3. /Synthetic Biology
  4. /Matū Group
Matū Group

Matū Group

DeepTech NativeAuckland, New ZealandActiveWebsiteLinkedIn
Stage FocusPre-Seed, Seed, Series A, Series B+
GeographyRest of World
TypeVC
Last Activity2025
Industry Focus
Industries
Synthetic BiologyAdvanced MaterialsMedTech
Technical BenchStrong
Investor TypeDeepTech Specialist
ExposureMostly DeepTech Investments
Bio

Matū Group was founded in 2018 in Auckland, investing in science and deep tech in Aotearoa New Zealand. The portfolio includes 17 active companies across a 3-fund structure: Karihi (pre-seed/seed nucleus fund), Ngota (Series A/B atom fund), and Iramoe (retail investor neutron fund via Catalist IPO in 2021).

Sectors span agtech, AI, biology, chemistry, cleantech, foodtech, industrial, materials, m...

Notable Investments
S
Synthase Biotech
A
Alimetry
P
PowerON
M
Mekonos

Similar Funds

The Production Board

The Production Board

San Francisco, United States

Pure DeepTechSynthetic BiologyAgriTechBiotechPre-SeedSeed
Flagship Pioneering

Flagship Pioneering

Cambridge, United States

Pure DeepTechSynthetic BiologyBiotechAgriTechPre-SeedSeed
GRIDX

GRIDX

Buenos Aires, Argentina

DeepTech NativeSynthetic BiologyBiotechAgriTechPre-SeedSeed
Blue Horizon

Blue Horizon

Zurich, Switzerland

DeepTech NativeSynthetic BiologyAgriTechClimate TechSeedSeries A
Illumina Ventures

Illumina Ventures

San Diego, United States

Pure DeepTechSynthetic BiologyBiotechMedTechSeedSeries A
iNovia Capital

iNovia Capital

Montreal, Canada

DeepTech NativeAI InfrastructureMedTechPre-SeedSeed
Joltoo
Privacy PolicyTerms of Service
© 2026 Joltoo. All rights reserved.